Inside informationEnglish
KURMA PARTNERS, A MEMBER OF THE EURAZEO GROUP AND FOUNDING INVESTOR OF IMCHECK THERAPEUTICS, ANNOUNCES THE SALE OF THE BIOTECH COMPANY TO IPSEN FOR UP TO €1 BILLION
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Eurazeo
- Filed
- 22/10/2025, 07:24
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 079986_20251022